Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
2.
Eur Rev Med Pharmacol Sci ; 25(9): 3399, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-34002808

RESUMEN

The article "Circular RNA circCRIM1 suppresses lung adenocarcinoma cell migration, invasion, EMT, and glycolysis through regulating miR-125b-5p/BTG2 axis, by S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-A. Zhang, Y.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3761-3774-DOI: 10.26355/eurrev_202004_20841-PMID: 32329853" has been withdrawn from the authors due to some technical reasons. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20841.

3.
Eur Rev Med Pharmacol Sci ; 25(8): 3150, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33928597

RESUMEN

The article "CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p, by S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3749-3760-DOI: 10.26355/eurrev_202004_20839-PMID: 32329852" has been withdrawn from the authors due to inaccuracies and mistakes. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20839.

4.
Eur Rev Med Pharmacol Sci ; 24(7): 3749-3760, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32329852

RESUMEN

OBJECTIVE: Circular RNAs (circRNAs) can make contributions to cell proliferation, migration and invasion in lung adenocarcinoma (LUAD). Circ_Band 4.1-like protein 2 (circ_EPB41L2) was found to have anti-tumor roles in lung cancer. Herein, we investigated the roles of circ_EPB41L2 in LUAD tumorigenicity. PATIENTS AND METHODS: The expression of circ_EPB41L2, microRNA (miR)-211-5p, and Cadherin-4 (CDH4) was measured using quantitative real-time polymerase chain reaction. Western blot was used to detect the levels of CDH4, Ki67, and E-cadherin. Cell proliferation, migration and invasion were examined using 3-(4,5)-dimethylthiazol(-z-y1)-3,5-di-phenyltetrazoliumbromide (MTT) assay and transwell assay, respectively. The interaction between miR-211-5p and circ_EPB41L2 or CDH4 was confirmed by Dual-Luciferase reporter assay. In vivo experiments were conducted using the murine xenograft model. RESULTS: Circ_EPB41L2 and CDH4 were down-regulated in LUAD tissues and cell lines. Overexpressed circ_EPB41L2 or CDH4 acted as a suppressor in the LUAD cell proliferation, invasion and migration in vitro. MiR-211-5p directly bound to circRNA_EPB41L2 and CDH4 3'-UTR, and circ_EPB41L2 indirectly regulated CDH4 expression by binding to miR-211-5p in LUAD cells. Furthermore, rescue assay showed circ_EPB41L2 played a protective role by repressing proliferation, migration and invasion through regulating CDH4 and miR-211-5p in LUAD cells. Besides, in vivo experiments indicated circ_EPB41L2 overexpression also inhibited tumor growth through regulating miR-211-5p and CDH4. CONCLUSIONS: Circ_EPB41L2 functioned as a tumor suppressor to inhibit the proliferation, migration and invasion through regulating CDH4 by miR-211-5p in LUAD cells, suggesting a new understanding on the tumorigenesis of LUAD and novel molecular therapeutic targets.


Asunto(s)
Adenocarcinoma del Pulmón/metabolismo , Cadherinas/metabolismo , Proteínas del Citoesqueleto/metabolismo , Neoplasias Pulmonares/metabolismo , Proteínas de la Membrana/metabolismo , MicroARNs/metabolismo , ARN Circular/metabolismo , Adenocarcinoma del Pulmón/patología , Cadherinas/genética , Movimiento Celular , Proliferación Celular , Células Cultivadas , Proteínas del Citoesqueleto/genética , Humanos , Neoplasias Pulmonares/patología , Proteínas de la Membrana/genética , MicroARNs/genética , ARN Circular/genética
5.
Eur Rev Med Pharmacol Sci ; 24(7): 3761-3774, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32329853

RESUMEN

OBJECTIVE: The present studies indicate that circRNAs play pivotal roles in human cancers. Lung adenocarcinoma (LUAC), one of lung cancer types, has high metastasis rate. Herein, we focused our study on the function and mechanism of circular RNA circCRIM1 in LUAC development. PATIENTS AND METHODS: Quantitative Real-time polymerase chain reaction (qRT-PCR) was performed to detect the levels of circCRIM1, miR-125b-5p, and BTG anti-proliferation factor 2 (BTG2). Transwell assay was carried out to assess cell migration and invasion. The protein levels of BTG2, EMT markers, and HK2 were measured by Western blot. Glycolysis was analyzed through determining glucose consumption and lactate production. Furthermore, the targets of circCRIM1 and miR-125b-5p were predicted and verified by starBase and the dual-luciferase reporter assay, respectively. Also, whether circCRIM1 affecting tumor growth in vivo was explored using mouse xenograft assay. RESULTS: CircCRIM1 and BTG2 were downregulated, and miR-125b-5p was upregulated in LUAC tissues/cells. CircCRIM1 upregulation inhibited LUAC cell migration, invasion, epithelial-mesenchymal transition (EMT), glycolysis, and tumor growth. Moreover, circCRIM1 regulated LUAC cell development through targeting miR-125b-5p. MiR-125b-5p affected LUAC cell growth via binding to BTG2. Also, circCRIM1 promoted BTG2 expression by inhibiting miR-125b-5p expression in LUAC cells. CONCLUSIONS: CircCRIM1 was lowly expressed in LUAC. Moreover, circCRIM1 functioned as a sponge of miR-125b-5p to improve BTG2 expression, thereby suppressing LUAC development. Our finding indicated that circCRIM1 could be considered as a biomarker and target for the diagnosis and therapy of LUAC patients.


Asunto(s)
Adenocarcinoma del Pulmón/metabolismo , Movimiento Celular , Transición Epitelial-Mesenquimal , Glucólisis , Proteínas Inmediatas-Precoces/metabolismo , Neoplasias Pulmonares/metabolismo , MicroARNs/metabolismo , ARN Circular/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Adenocarcinoma del Pulmón/patología , Proliferación Celular , Células Cultivadas , Humanos , Proteínas Inmediatas-Precoces/genética , Neoplasias Pulmonares/patología , MicroARNs/genética , Invasividad Neoplásica , ARN Circular/genética , Proteínas Supresoras de Tumor/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...